Torecan and Tendonitis - a phase IV clinical study of FDA data

Summary:

Tendonitis is reported as a side effect among people who take Torecan (thiethylperazine maleate), especially for people who are female, 50-59 old, also take Ms Contin, and have Breast cancer.

The phase IV clinical study analyzes which people have Tendonitis when taking Torecan. It is created by eHealthMe based on reports of 406 people who have side effects when taking Torecan from the FDA, and is updated regularly.

What is Torecan?

Torecan has active ingredients of thiethylperazine maleate. eHealthMe is studying from 406 Torecan users. Check the latest studies of Torecan.

What is Tendonitis?

Tendonitis (a condition that causes pain and swelling of tendons) is found to be associated with 1,098 drugs and 1,274 conditions by eHealthMe. Check the latest studies of Tendonitis.



On Aug, 09, 2026

406 people reported to have side effects when taking Torecan.
Among them, 23 people (5.67%) have Tendonitis.

Could Torecan cause Tendonitis?

Among these 23 people:

What is the gender of people who have Tendonitis when taking Torecan? *

  • female: 78.26 %
  • male: 21.74 %

What is the age of people who have Tendonitis when taking Torecan? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 95.45 %
  • 60+: 4.55 %

What are other drugs people take besides Torecan? *

  1. Zometa: 23 people, 100.00%
  2. Neurontin: 23 people, 100.00%
  3. Aredia: 23 people, 100.00%
  4. Ativan: 23 people, 100.00%
  5. Celebrex: 23 people, 100.00%
  6. Ms Contin: 23 people, 100.00%
  7. Diflucan: 22 people, 95.65%
  8. Adriamycin Pfs: 21 people, 91.30%
  9. Taxotere: 18 people, 78.26%
  10. Cimetidine: 18 people, 78.26%

What are other side effects people have besides Tendonitis? *

  1. Liver Function Test Abnormal: 23 people, 100.00%
  2. Diverticulum Intestinal (a pouch that is attached to the first part of the small intestine): 23 people, 100.00%
  3. Intervertebral Disc Protrusion (spinal disc protrusion): 23 people, 100.00%
  4. Tumor: 23 people, 100.00%
  5. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 23 people, 100.00%
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 23 people, 100.00%
  7. Osteosclerosis (an elevation in bone density): 23 people, 100.00%
  8. Bone Disorder: 23 people, 100.00%
  9. Fungal Nail Infection: 23 people, 100.00%
  10. Rib Fracture: 22 people, 95.65%

What are the existing conditions these people have? *

  1. Ovarian Cancer (cancer of ovary): 18 people, 78.26%
  2. Neoplasm Malignant (cancer tumour): 18 people, 78.26%
  3. Migraine (headache): 18 people, 78.26%
  4. Hot Flush (sudden feelings of heat): 18 people, 78.26%
  5. Discomfort: 18 people, 78.26%
  6. Breast Cancer Metastatic: 18 people, 78.26%
  7. Breast Cancer: 18 people, 78.26%
  8. Granulocyte Count Decreased: 17 people, 73.91%
  9. Herpes Zoster: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Torecan and have Tendonitis?

- Check whether Tendonitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Torecan:

Tendonitis treatments and more:

How severe was Tendonitis and when was it recovered:

Expand to all the drugs that have ingredients of thiethylperazine maleate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Torecan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tendonitis:

Browse all the conditions that are associated with Tendonitis:


How the study uses the data?

The study uses data from the FDA. It is based on thiethylperazine maleate (the active ingredients of Torecan) and Torecan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: